Princeton Alpha Management’s Medicines Co MDCO Stock Holding History

Princeton Alpha Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,286	Closed	-$503K	–	462
2017 Q1	$503K	Sell	10,286 -3,168	-24%	-$144K	0.17%	197
2016 Q4	$457K	Buy	+13,454	New	+$477K	0.09%	332
2015 Q2	–	Sell	-9,642	Closed	-$270K	–	964
2015 Q1	$270K	Buy	+9,642	New	+$271K	0.06%	503

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Princeton Alpha Management's MDCO Position: Q2 2017 in Review

Princeton Alpha Management sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 10,286 shares — an estimated $503K sold.

Princeton Alpha Management first reported a position in MDCO in Q1 2015 and held it in 3 quarters. The position peaked at $503K in Q1 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

Princeton Alpha Management reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 10,286 Medicines Co shares in Q2 2017, an estimated $503K.
Princeton Alpha Management first reported a position in Medicines Co in Q1 2015 and held it in 3 quarters.
Princeton Alpha Management's Medicines Co position peaked at $503K in Q1 2017.
202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.